Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB – Is one NUC better than the other?

Grace Lai Hung Wong, Pietro Lampertico

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)453-455
JournalJournal of Hepatology
Issue number3
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Hepatology

Cite this